Results: 1-9 |
Results: 9

Authors: Neri, N Aviles, A Cleto, S Diaz, N Talavera, A Garcia, EL Diaz-Maqueo, JC
Citation: N. Neri et al., Chemotherapy plus interferon-alpha 2b versus chemotherapy in the treatmentof follicular lymphoma, J HEMATH ST, 10(5), 2001, pp. 669-674

Authors: Aviles, A Leon, MI Diaz-Maqueo, JC Garcia, EL Cleto, S Neri, N
Citation: A. Aviles et al., Rituximab in the treatment of refractory follicular lymphoma - Six doses are better than four, J HEMATH ST, 10(2), 2001, pp. 313-316

Authors: Aviles, A Talavera, A Diaz-Maqueo, JC Garcia, E Cleto, S Neri, N
Citation: A. Aviles et al., Evaluation on a six-dose treatment of anti CD 20 monoclonal antibody in patients with refractory follicular lymphoma, CANC BIO R, 16(2), 2001, pp. 159-162

Authors: Aviles, A Diaz-Maqueo, JC Garcia, EL Talavera, A Huerta-Guzman, J Neri, N
Citation: A. Aviles et al., Late lethal events in patients with diffuse large B cell lymphoma: A review of 714 patients treated in a single centre, LEUK LYMPH, 42(4), 2001, pp. 631-637

Authors: Bozzia, C Carassiti, V Ramusino, AC Dittongo, S Folegani, M Piemontese, L Abbott, BK Breon, AB Clark, AR Dow, S Fan, Q Goozen, F Hernikl, C Karcher, A Kerth, LT Kipnis, I Kluth, S Lynch, G Levi, M Luft, P Luo, L Nyman, M Pedrali-Noy, M Roe, NA Zizka, G Roberts, D Schieck, J Barni, D Brenna, E Defendi, I Forti, A Giugni, D Lanni, F Palombo, F Vaniev, V Leona, A Mandelli, E Manfredi, PF Perazzo, A Re, V Angelini, C Batignani, G Bettarini, S Bondioli, M Bosi, F Calderini, G Carpinelli, M Forti, F Gagliardi, D Giorgi, MA Lusiani, A Mammini, P Morganti, M Morsani, F Neri, N Paoloni, E Profeti, A Rama, M Rampino, G Rizzo, G Sandrelli, F Simi, G Triggiani, G Tritto, S Vitale, R Walsh, J Burchat, P Cheng, C Kirkby, D Meyer, T Roat, C Bona, M Bianchi, F Daudo, F Di Girolamo, B Gamba, D Giraudo, G Grosso, P Romero, A Smol, A Trapani, P Zanin, D Bosisio, L Della Ricca, G Rashevskaia, I Lanceri, L Pompili, A Poropat, P Prest, M Rastelli, C Vallazza, E Vuagnin, G Hast, C Potter, EP Sharma, V Burke, S Callahan, D Campagnari, C Dahmes, B Eppich, A Hale, D Hall, K Hart, P Kuznetsova, N Kyre, S Levy, S Long, O May, J Richman, J Verkerke, W Witherell, M Beringer, J Eisner, AM Frey, A Grillo, A Grothe, M Johnson, R Kroeger, W Lockman, W Pulliam, T Rowe, W Schmitz, R Seiden, A Spencer, E Turri, M Walkowiak, W Wilder, M Charles, E Elmer, P Nielsen, J Orejudos, W Scott, I Zobernig, H
Citation: C. Bozzia et al., First-year experience with the BaBar silicon vertex tracker, NUCL INST A, 473(1-2), 2001, pp. 7-16

Authors: Huerta-Zepeda, A Talavera, A Aviles, A Neri, N Mayani, H
Citation: A. Huerta-zepeda et al., In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy, LEUK LYMPH, 39(5-6), 2000, pp. 613-624

Authors: Aviles, A Neri, N Cuadra, I Alvarado, I Cleto, S
Citation: A. Aviles et al., Second lethal events associated with treatment for Hodgkin's disease: A review of 2980 patients treated in a single Mexican institute, LEUK LYMPH, 39(3-4), 2000, pp. 311-319

Authors: Aviles, A Diaz, NR Neri, N Cleto, S Talavera, A
Citation: A. Aviles et al., Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients, CLIN LAB H, 22(4), 2000, pp. 215-220

Authors: Aviles, A Talavera, A Diaz, NR Neri, N
Citation: A. Aviles et al., Interferon as maintenance therapy in refractory malignant lymphoma, J HEMATOTH, 8(3), 1999, pp. 263-267
Risultati: 1-9 |